Axsome Therapeutics (AXSM) Treasury Shares (2020 - 2026)

Axsome Therapeutics (AXSM) has 7 years of Treasury Shares data on file, last reported at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 31.68% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 31.68% YoY), and the FY2025 full-year result was $1.0 million, up 11.67% from the prior year.
• Treasury Shares improved to $1.3 million in Q1 2026, from $1.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $1.3 million in Q1 2026 to a low of $667366.0 in Q1 2022.
• A 5-year average of $876798.3 and a median of $893055.0 in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares surged 130.75% in 2022 and advanced 7.65% in 2025, its largest moves.
• Tracing AXSM's Treasury Shares over 5 years: stood at $686375.0 in 2022, then grew by 17.16% to $804150.0 in 2023, then increased by 12.78% to $906944.0 in 2024, then rose by 11.67% to $1.0 million in 2025, then advanced by 29.13% to $1.3 million in 2026.
• Business Quant data shows AXSM's Treasury Shares at $1.3 million in Q1 2026, $1.0 million in Q4 2025, and $1.0 million in Q3 2025.